{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380302865543092791.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Satoru Muto"}],"foaf:familyName":[{"@value":"Muto"}],"foaf:givenName":[{"@value":"Satoru"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360302865543092736","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1007/s10157-023-02372-8"},{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1007/s10157-023-02372-8.pdf"},{"@type":"URI","@value":"https://link.springer.com/article/10.1007/s10157-023-02372-8/fulltext.html"},{"@type":"PMID","@value":"37924433"}],"notation":[{"@value":"Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1007/s10157-023-02372-8_URJxqeZcuhE4RYNFphTpurAZnQG"},{"@type":"OPENAIRE","@value":"doi_dedup___::b1e7b4aabda86a40b43b582c8324e106_URJxqeZcuhE4RYNFphTpurAZnQG"}]}